MPSIIIA

17 stories · following the connections

Business

Abeona Therapeutics Enrolls First High Dose Subject in Ongoing Phase 1/2 Gene Therapy Clinical Trial in Sanfilippo Syndrome Type A

By Nasdaq OMXFeb 1, 2017, 12:43 PM UTC